These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 38859965

  • 21. Predictive Value of Plasma Atherogenic Index for Microalbuminuria in Newly Diagnosed Patients with Type 2 Diabetes Mellitus.
    Qi L, Kang N, Chen X, Li Z, Deng C, Chen S.
    Diabetes Metab Syndr Obes; 2022; 15():1245-1252. PubMed ID: 35480850
    [Abstract] [Full Text] [Related]

  • 22. Correlation between urine vitamin D-binding protein and early-stage renal damage in Type 2 diabetes.
    Huang Y, Chen S, Dai Q, Zhang H, Liu Y.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Jan 28; 48(1):40-48. PubMed ID: 36935176
    [Abstract] [Full Text] [Related]

  • 23. Implications of increased circulating macrophage inhibitory protein-5 in patients with type 2 diabetes mellitus.
    Zhao B, Zhang M, Xie J, Jiang T, Li J, Yang Z.
    Int Immunopharmacol; 2022 Aug 28; 109():108916. PubMed ID: 35679662
    [Abstract] [Full Text] [Related]

  • 24. Serum Human Epididymis Protein 4 is Associated with Renal Function and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus.
    Zhang M, Zhao B, Xie J, Liang Y, Yang Z.
    Biomed Res Int; 2019 Aug 28; 2019():4831459. PubMed ID: 31815140
    [Abstract] [Full Text] [Related]

  • 25. Elevated RHAMM as a biomarker for predicting diabetic kidney disease in patients with type 2 diabetes.
    Qi B, Lou Y, Zhu Y, Chen Y, Yang S, Meng F, Pan Z, Liu S, Yan G, Lu X, Huang LH.
    Clin Kidney J; 2024 Jul 28; 17(7):sfae196. PubMed ID: 39050866
    [Abstract] [Full Text] [Related]

  • 26. Serum lutein is a promising biomarker for type 2 diabetes mellitus and diabetic kidney disease in the elderly.
    Pan F, Cui W, Gao L, Shi X, Yang H, Hu Y, Li M.
    J Clin Lab Anal; 2022 Apr 28; 36(4):e24350. PubMed ID: 35293029
    [Abstract] [Full Text] [Related]

  • 27. Diagnostic value of quantitative contrast-enhanced ultrasound (CEUS) for early detection of renal hyperperfusion in diabetic kidney disease.
    Wang L, Wu J, Cheng JF, Liu XY, Ma F, Guo LH, Xu JM, Wu T, Mohan C, Peng A, Xu HX, Song YX.
    J Nephrol; 2015 Dec 28; 28(6):669-78. PubMed ID: 25712236
    [Abstract] [Full Text] [Related]

  • 28. The unique association between the level of plateletcrit and the prevalence of diabetic kidney disease: a cross-sectional study.
    Wei S, Pan X, Xiao Y, Chen R, Wei J.
    Front Endocrinol (Lausanne); 2024 Dec 28; 15():1345293. PubMed ID: 38726343
    [Abstract] [Full Text] [Related]

  • 29. Serum hemoglobin concentration and risk of renal function decline in early stages of diabetic kidney disease: a nationwide, biopsy-based cohort study.
    Yamanouchi M, Furuichi K, Shimizu M, Toyama T, Yamamura Y, Oshima M, Kitajima S, Hara A, Iwata Y, Sakai N, Oba Y, Matsuoka S, Ikuma D, Mizuno H, Suwabe T, Hoshino J, Sawa N, Yuzawa Y, Kitamura H, Suzuki Y, Sato H, Uesugi N, Ueda Y, Nishi S, Yokoyama H, Nishino T, Samejima K, Kohagura K, Shibagaki Y, Makino H, Matsuo S, Ubara Y, Wada T.
    Nephrol Dial Transplant; 2022 Feb 25; 37(3):489-497. PubMed ID: 34028524
    [Abstract] [Full Text] [Related]

  • 30. Association between hemoglobin glycation index and diabetic kidney disease in type 2 diabetes mellitus in China: A cross- sectional inpatient study.
    Xin S, Zhao X, Ding J, Zhang X.
    Front Endocrinol (Lausanne); 2023 Feb 25; 14():1108061. PubMed ID: 36967789
    [Abstract] [Full Text] [Related]

  • 31. Circulating asprosin levels are increased in patients with type 2 diabetes and associated with early-stage diabetic kidney disease.
    Zhang H, Hu W, Zhang G.
    Int Urol Nephrol; 2020 Aug 25; 52(8):1517-1522. PubMed ID: 32458209
    [Abstract] [Full Text] [Related]

  • 32. A cohort study on the correlation between serum uric acid trajectory and the progression of renal function in patients with Type 2 diabetes mellitus.
    Pan J, Yang Q, Peng J, Li A, Liu Y, Yi B.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May 28; 48(5):725-732. PubMed ID: 37539575
    [Abstract] [Full Text] [Related]

  • 33. Association of systemic immune-inflammation index with diabetic kidney disease in patients with type 2 diabetes: a cross-sectional study in Chinese population.
    Yan P, Yang Y, Zhang X, Zhang Y, Li J, Wu Z, Dan X, Wu X, Chen X, Li S, Xu Y, Wan Q.
    Front Endocrinol (Lausanne); 2023 May 28; 14():1307692. PubMed ID: 38239983
    [Abstract] [Full Text] [Related]

  • 34. Cardiovascular risk and renal injury profile in subjects with type 2 diabetes and non-albuminuric diabetic kidney disease.
    Di Marco M, Scilletta S, Miano N, Marrano N, Natalicchio A, Giorgino F, Di Mauro S, Filippello A, Scamporrino A, Tribulato P, Bosco G, Di Giacomo Barbagallo F, Scicali R, Milluzzo A, Ballirò T, Frittitta L, Castellino P, Purrello F, Piro S, Di Pino A.
    Cardiovasc Diabetol; 2023 Dec 13; 22(1):344. PubMed ID: 38093293
    [Abstract] [Full Text] [Related]

  • 35. Assessment of urinary NGAL for differential diagnosis and progression of diabetic kidney disease.
    Duan S, Chen J, Wu L, Nie G, Sun L, Zhang C, Huang Z, Xing C, Zhang B, Yuan Y.
    J Diabetes Complications; 2020 Oct 13; 34(10):107665. PubMed ID: 32653382
    [Abstract] [Full Text] [Related]

  • 36. A study of the natural history of diabetic kidney disease (DKD).
    Altemtam N, Russell J, El Nahas M.
    Nephrol Dial Transplant; 2012 May 13; 27(5):1847-54. PubMed ID: 22058177
    [Abstract] [Full Text] [Related]

  • 37. Quantitative assessment of renal steatosis in patients with type 2 diabetes mellitus using the iterative decomposition of water and fat with echo asymmetry and least squares estimation quantification sequence imaging: repeatability and clinical implications.
    Liu J, Wu Y, Tian C, Zhang X, Su Z, Nie L, Wang R, Zeng X.
    Quant Imaging Med Surg; 2024 Oct 01; 14(10):7341-7352. PubMed ID: 39429570
    [Abstract] [Full Text] [Related]

  • 38. Extracellular status of thrombospondin-2 in type 2 diabetes mellitus and utility as a biomarker in the determination of early diabetic kidney disease.
    Lin Z, Zhang D, Zhang X, Guo W, Wang W, Zhang Y, Liu Z, Bi Y, Wu M, Lin Z, Lu X.
    BMC Nephrol; 2023 May 31; 24(1):154. PubMed ID: 37259071
    [Abstract] [Full Text] [Related]

  • 39. Serum high mobility group box 1 as a potential biomarker for the progression of kidney disease in patients with type 2 diabetes.
    Liu T, Zhao H, Wang Y, Qu P, Wang Y, Wu X, Zhao T, Yang L, Mao H, Peng L, Zhan Y, Li P.
    Front Immunol; 2024 May 31; 15():1334109. PubMed ID: 38481996
    [Abstract] [Full Text] [Related]

  • 40. Association of Systemic Immune-Inflammation Index and Systemic Inflammation Response Index with Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus.
    Liu W, Zheng S, Du X.
    Diabetes Metab Syndr Obes; 2024 May 31; 17():517-531. PubMed ID: 38327734
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.